Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status

British Journal of Cancer

Volumn 71, Issue 5, 1995, Pages 981-985

  McCann, A H ^a,b   Kirley, A ^a,b   Carney, D N ^c   Corbally, N ^c   Magee, H M ^a,b   Keating, G ^a,b   Dervan, P A ^a,b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b UCD   (Ireland)

^c MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Amplification; Breast; MDM2; Microwave; P53

Indexed keywords

CELL NUCLEUS DNA; PROTEIN P53; TRANSCRIPTION FACTOR;

ARTICLE; BREAST CARCINOMA; CANCER GENETICS; CELL NUCLEUS; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; PRIORITY JOURNAL; SOUTHERN BLOTTING;

BLOTTING, SOUTHERN; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CARCINOMA IN SITU; CARCINOMA, INFILTRATING DUCT; DNA, NEOPLASM; FEMALE; FORMALDEHYDE; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MICROWAVES; NEOPLASM PROTEINS; PARAFFIN EMBEDDING; PROTEIN P53; PROTO-ONCOGENE PROTEINS; SUPPORT, NON-U.S. GOV'T; TISSUE FIXATION;

EID: 0029020147     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1995.189     Document Type: Article

References (28)

1. BARNES DM, HANBY AM, GILLETT CE, MOHAMMED S, HODGSON S, BOBROW LG, LEIGH IM, PURKIS T, MACGEOCH C, SPURR NK, BARTER J, VOJTESEK B, PICKSLEY SM AND LANE DP. (1992). Abnormal expression of wild type p53 protein in normal cells of a cancer family patient. Lancet, 340, 259–263.
2. BUESO-RAMOS CE, YANG Y, DELEON E, McCOWN P, STASS SA, AND ALBITAR M. (1993). The human MDM2 oncogene is overexpressed in leukemias. Blood’, 82, 2617–2623.
3. CAHILLY-SNYDER L, YANG-FENG T, FRANCKE U, AND GEORGE DL. (1987). Molecular analysis, AND chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line. Somatic Cell. Mol. Genet., 13, 235–244.
4. FAKHARZADEH SS, TRUSKO SP, AND GEORGE DL. (1991). Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumour cell line. EM BO J., 10, 1565–1569.
5. FEARON ER, CHO KR, NIGRO JM, KERN SE, SIMONS JW, RUPPERT JM, HAMILTON SR, PREISINGER AC, THOMAS G, KINZLER KW, AND VOGELSTEIN B. (1990). Identification of a chromosome 18q gene that is altered in colorectal cancers. Science, 247, 49–56.
6. FINLAY C. (1993). The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth. Mol. Cell. Biol., 13, 301–306.
7. GOWN AM, DE WEVER N, AND BATTIFORA H. (1993). Microwave-based antigenic unmasking: a revolutionary new technique for routine immunohistochemistry. Appl. Immunol., 1, 256–266.
8. KELLEHER L, MAGEE HM, AND DERVAN PA. (1994). Evaluation of cell proliferation antibodies reactive in paraffin sections. Appl. Immunol., 2, 164–170.
9. KESSIS TD, SLEBOS RJ, HAN SM, SHAH K, BOSCH XF, MUNOZ N, HEDRICK L, AND CHO KR. (1993). p53 gene mutations, AND MDM2 amplification are uncommon in primary carcinomas of the uterine cervix. Am. J. Pathol., 143, 1398–1405.
10. KHATIB ZA, MATSUSHIME H, VALENTINE M, SHAPIRO DN, SHERR CJ, AND LOOK AT. (1993). Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res., 53, 5535–5541.
11. KOVAR H, AUINGER A, JUG G, ARYEE D, ZOUBEK A, SALZER-KUNTSCHIK M, AND GADNER H. (1993). Narrow spectrum of infrequent p53 mutations, AND absence of MDM2 amplification in Ewing tumours. Oncogene, 8, 2683–2690.
12. LADANYI M, CHA C, LEWIS R, JHANWAR SC, HUVOS AG, AND HEALY JH. (1993). MDM2 gene amplification in metastatic osteocarcinoma. Cancer Res., 53, 16–18.
13. LEACH FS, TOKINO T, MELTZER P, BURRELL M, OLINER JD, SMITH S, HILL DE, SIDRANSKY D, KINZLER KW, AND VOGELSTEIN B. (1993a). p53 mutation, AND MDM2 amplification in human soft tissue sarcomas. Cancer Res., 53, 2231–2234.
14. LEACH FS, NICOLAIDES NC, PAPADOPOULOS N, LIU B, JEN J, PARSONS R, PELOMAKI P, SISTONEN P, AALTONEN LA, NYSTROM-LAHTI M, GUAN XY, ZHANG J, MELTZER PS, YU J-W, KAO F-T, CHEN DJ, CEROSALETTI KM, FOURNIER REK, TODD S, LEWIS T, LEACH RJ, NAYLOR SL, WEISSENBACH J, MECKLIN, JARVINEN H, PETORSEN GM, HAMILTON SR, GREEN J, JASS J, WATSON P, LYNCH HT, TRENT JM, DE LA CHAPELLE A, KINZLER KW, AND VOGELSTEIN B. (1993b). Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell, 75, 1215–1225.
15. MOMAND J, ZAMBETTI GP, OLSON DC, GEORGE D, AND LEVINE AJ. (1992). The mdm-2 oncogene product forms a complex with the p53 protein, AND inhibits p53-mediated transactivation. CeU, 69, 1237–1245.
16. OLINER JD, KJNZLER KW, MELTZER PS, GEORGE DL, AND VOGELSTEIN B. (1992). Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature, 358, 80–83.
17. OLINER JD, PIETENPOL JA, THIAGALINGAM S, GYURIS J, KJNZLER KW, AND VOGELSTEIN B. (1993). Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature, 362, 857–860.
18. OLSON DC. MARECHAL V. MOMAND J. CHEN J, ROMOCKI C, AND LEVINE AJ. (1993). Identification, AND characterisation of multiple mdm-2 proteins, AND mdm-2-p53 protein complexes. Oncogene, 8, 2353–2360.
19. PREUDHOMME C, QUESNEL B, VACHEE A, LEPELLEY P, COLLYND’HOOGHE M, WATTEL E, AND FENAUX P. (1993). Absence of amplification of MDM2 gene, a regulator of p53 function, in myelodysplastic syndromes. Leukemia, 7, 1291–1293.
20. PROSSER J, ELDER PA, CONDIE A, MACFADYEN I, STEEL CM, AND EVANS HJ. (1991). Mutations in p53 do not account for heritable breast cancer a study in five affected families. Br. J. Cancer, 63, 181–184.
21. REIFENBERGER G, LIU L, ICHIMURA K, SCHMIDT EF, AND COLLINS VP. (1993). Amplification, AND overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res., 53, 2736–2739.
22. RUBIO M-P, VON DREMUNG A. YANDELL DW. WIESTLER OD, GUSELLA JF, AND LOUIS DN. (1993). Accumulation of wild type p53 protein in human astrocytomas. Cancer Res., 53, 3465–3467.
23. SHEIKH MS, SHAO Z-M, HUSSAIN A, AND FONTANA JA. (1993). The p53 binding protein MDM2 gene is differentially expressed in human breast carcinoma. Cancer Res., 53, 3226–3228.
24. SHI SR, KEY ME, AND KALRA KL. (1991). Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J. His toe hem. Cvtochem., 39, 741–748.
25. SINGH S, SIMON M, MEYBOHM I, JANTKE I, JONAT W, MAASS H, AND GOEDDE HW. (1993). Human breast cancer frequent p53 allele loss, AND protein overexpression. Hum. Genet., 90, 635–640.
26. WARREN W. EELES RA. PONDER BAJ, EASTON DF, AVERILL D. PONDER MA, ANDERSON K, EVANS AM, DEMARS R. LOVE R. DUNDAS S, STRATTON MR. TROWBRIDGE P. COOPER CS, AND PETO J. (1992). No evidence for germline mutations in exons 5-9 of the p53 gene in 25 breast cancer families. Oncogene, 7, 1043–1046.
27. YOSHIDA T. SALAMOTO H, AND TERADA M. (1993). Amplified genes in cancer upper digestive tract. Semin. Cancer Biol., 4, 33–40.
28. WU X, BAYLE H. OLSON D, AND LEVINE AJ (1993). The p53-mdm-2 autoregulatory feedback loop. Genes Dew, 7, 1126–1132.